Immunovant
Price & Volume
Stats
See moreOpen | $43.54 |
Previous Close | $43.50 |
Day Range | $42.68-$44.20 |
52W Range | $14.47-$45.42 |
Market Cap | $8.9B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.82 |
News
See moreYahoo Finance • last month
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
Yahoo Finance • 3 months ago
H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data
Yahoo Finance • 3 months ago
Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine
Yahoo Finance • 3 months ago
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
About
CEO | Dr. Eric Venker M.D., Pharm.D. |
Address | 1000 Park Forty Plaza, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 315 |